Table 2 Comparison of anthropometric and metabolic parameters between cases and controls.

From: UCP3 gene variants and obesity in a Pakistani sample population

Parameters

Groups

Mean ranks

p-value

p-value (corrected)

Anthropometric parameters

Weight (kg)

Cases

298.76

< 0.001

< 0.001

Controls

102.24

Height (cm)

Cases

192.65

0.174

0.138

Controls

208.35

Body mass index (kg/m2)

Cases

300.50

< 0.001

< 0.001

Controls

100.50

Waist circumference (cm)

Cases

294.54

< 0.001

< 0.001

Controls

106.47

Hip circumference (cm)

Cases

294.15

< 0.001

< 0.001

Controls

106.86

Waist-to-height ratio

Cases

294.12

< 0.001

< 0.001

Controls

106.88

Waist-to-hip ratio

Cases

270.47

< 0.001

< 0.001

Controls

130.53

Biceps skinfold thickness (mm)

Cases

280.43

< 0.001

< 0.001

Controls

120.57

Triceps skinfold thickness (mm)

Cases

292.89

< 0.001

< 0.001

Controls

108.12

Abdomen skinfold thickness (mm)

Cases

289.90

< 0.001

< 0.001

Controls

111.10

Supra-iliac skinfold thickness (mm)

Cases

286.59

< 0.001

< 0.001

Controls

114.41

Thigh skinfold thickness (mm)

Cases

296.51

< 0.001

< 0.001

Controls

104.49

Subscapular skinfold thickness (mm)

Cases

289.32

< 0.001

< 0.001

Controls

111.68

Body fat percentage (%)

Cases

297.68

< 0.001

< 0.001

Controls

103.32

Metabolic parameters

Systolic blood pressure (mmHg)

Cases

231.63

< 0.001

< 0.001

Controls

169.37

Diastolic blood pressure (mmHg)

Cases

228.36

< 0.001

< 0.001

Controls

172.65

Fasting blood glucose (mg/dL)

Cases

222.43

< 0.001

< 0.001

Controls

178.58

Insulin concentration (µU/mL)

Cases

245.97

< 0.001

< 0.001

Controls

155.03

Homeostatic model assessment-insulin resistance

Cases

248.54

< 0.001

< 0.001

Controls

152.46

Total cholesterol (mg/dL)

Cases

161.40 ± 36.15a

0.001 a

< 0.001

Controls

148.56 ± 38.63a

Triglycerides (mg/dL)

Cases

238.33

< 0.001

< 0.001

Controls

162.68

High-density-lipoprotein cholesterol (mg/dL)

Cases

200.67

0.977

0.751

Controls

200.33

Low-density-lipoprotein cholesterol (mg/dL)

Cases

241.92

< 0.001

< 0.001

Controls

159.09

Very-low-density-lipoprotein cholesterol (mg/dL)

Cases

236.10

< 0.001

< 0.001

Controls

164.90

Coronary risk index

Cases

218.11

0.002

< 0.001

Controls

182.89

Atherogenic index

Cases

239.57

< 0.001

< 0.001

Controls

161.44

Triglycerides-to- High-density-lipoprotein cholesterol ratio

Cases

232.15

< 0.001

< 0.001

Controls

168.85

Visceral adiposity index

Cases

234.93

< 0.001

< 0.001

Controls

166.08

Lipid accumulation product

Cases

284.16

< 0.001

< 0.001

Controls

116.85

Product of triglycerides and glucose

Cases

242.61

< 0.001

< 0.001

Controls

158.39

  1. The comparison of all continuous variables between cases (individuals with obesity) and normal-BMI controls was done by Mann Mann-Whitney U test because of non-normal distribution. The mean ranks and p-values are provided. Mean ± standard deviation and p-value of cholesterol was detected by t-test due to normality of dataa. The correction for multiple testing was performed by the Benjamini–Hochberg method. The p-value < 0.05 was considered statistically significant (shown in bold). Coronary risk index was taken as the ratio of total cholesterol and high-density-lipoprotein cholesterol, whereas atherogenic index was taken as the ratio of low-density-lipoprotein cholesterol and high-density-lipoprotein cholesterol.
Back to article page